Norfolk Southern prices $500M 4.45% Senior Notes due 2033

NORFOLK SOUTHERN CORP

$500M aggregate principal of 4.450% Senior Notes due 2033, issued at 99.650% of par.
Net proceeds of ~$494M after underwriting discount and expenses, for general corporate purposes.
Offering expected to close Feb 2, 2023; underwriters include Citigroup, Goldman Sachs, U.S. Bancorp.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

NORFOLK SOUTHERN CORP entered into Underwriting Agreement with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters named therein valued at $500,000,000 aggregate principal amount (effective 2023-01-26).

Action: entry
Agreement: underwriting
Counterparty: Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters named therein
Value: $500,000,000 aggregate principal amount
Effective: 2023-01-26

Exact text from the filing

On January 26, 2023, Norfolk Southern Corporation (the “Registrant”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters named therein, to issue and sell $500,000,000 aggregate principal amount of the Registrant’s 4.450% Senior Notes due 2033 (the “Notes”) at a public offering price equal to 99.650% of the aggregate principal amount of the Notes (the “Offering”).

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

NORFOLK SOUTHERN CORP filing history →

Source: SEC EDGAR

accession 0001552781-23-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.